Health
Convalescent plasma is still in demand. But there are caveats – ABC News
This is a Kaiser Health News story.
Six months after it was controversially hailed by Trump administration officials as a breakthrough therapy to fight the worst effects of covid-19, convalescent plasma appears to be on the ropes.
The treatment that infuses blood plasma from recovered covid patients into people newly infected in hopes of boosting their immune response has not lived up to early hype. Some high-profile clinical trials have shown disappointing results. Demand from hospitals for the…
-
Noosa News11 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
General18 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
General23 hours agoRabbi Eli Schlanger killed in Bondi terror attack